| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2022 | AXOSIM, INC. | 1441 CANAL ST STE 206 | NEW ORLEANS | LA | 70112-2714 | ORLEANS | USA | SB1TR001270 | Peripheral Nerve-on-a-chip for Predictive Preclinical Pharmaceutical Testing | 000 | 4 | NIH | 1/8/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| | 2023 | 2022 | AXOSIM, INC. | 1441 CANAL STREET | NEW ORLEANS | LA | 70112-2714 | ORLEANS | USA | SB1TR001270 | Peripheral Nerve-on-a-chip for Predictive Preclinical Pharmaceutical Testing | 000 | 4 | NIH | 8/4/2023 | $0 |
| | 2023 | 2020 | AXOSIM, INC. | 1441 CANAL STREET | NEW ORLEANS | LA | 70112-2714 | ORLEANS | USA | R43ES032361 | Myelinated Rodent Brain Spheroids for High-throughput Evaluation of Neurotoxicity | 000 | 1 | NIH | 12/1/2022 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $299,226 ) |
| | 2022 | 2022 | AXOSIM, INC. | 1441 CANAL ST STE 206 | NEW ORLEANS | LA | 70112-2714 | ORLEANS | USA | SB1TR001270 | Peripheral Nerve-on-a-chip for Predictive Preclinical Pharmaceutical Testing | 000 | 4 | NIH | 3/16/2022 | $299,226 |
|
| Issue Date FY: 2021 ( Subtotal = $0 ) |
| | 2021 | 2020 | AXOSIM, INC. | 1441 CANAL ST STE 206 | NEW ORLEANS | LA | 70112-2714 | ORLEANS | USA | R43ES032361 | Myelinated Rodent Brain Spheroids for High-throughput Evaluation of Neurotoxicity | 000 | 1 | NIH | 7/13/2021 | $0 |
| | 2021 | 2020 | AXOSIM, INC. | 1441 CANAL ST STE 206 | NEW ORLEANS | LA | 70112-2714 | ORLEANS | USA | R43ES032361 | Myelinated Rodent Brain Spheroids for High-throughput Evaluation of Neurotoxicity | 001 | 1 | NIH | 7/23/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $227,946 ) |
| | 2020 | 2020 | AXOSIM, INC. | 1441 CANAL ST STE 206 | NEW ORLEANS | LA | 70112-2714 | ORLEANS | USA | R43ES032361 | Myelinated Rodent Brain Spheroids for High-throughput Evaluation of Neurotoxicity | 000 | 1 | NIH | 9/8/2020 | $227,946 |
| | 2020 | 2018 | AXOSIM, INC. | 1441 CANAL ST STE 206 | NEW ORLEANS | LA | 70112-2714 | ORLEANS | USA | R42TR001270 | Peripheral Nerve-on-a-chip for Predictive Preclinical Pharmaceutical Testing | 000 | 3 | NIH | 3/5/2020 | $0 |
| | 2020 | 2018 | AXOSIM, INC. | 1441 CANAL ST STE 206 | NEW ORLEANS | LA | 70112-2714 | ORLEANS | USA | R43ES029886 | Development of 3D Rat Nerve-on-a-Chip Model for Chemical Toxicity Screening | 000 | 1 | NIH | 8/26/2020 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $1,317,412 ) |
| | 2018 | 2018 | AXOSIM TECHNOLOGIES LLC | 1441 CANAL ST | NEW ORLEANS | LA | 70112-2714 | ORLEANS | USA | R42TR001270 | Peripheral Nerve-on-a-chip for Predictive Preclinical Pharmaceutical Testing | 000 | 2 | NIH | 12/16/2017 | $39,927 |
| | 2018 | 2018 | AXOSIM, INC. | 1441 CANAL ST STE 206 | NEW ORLEANS | LA | 70112-2714 | ORLEANS | USA | R42TR001270 | Peripheral Nerve-on-a-chip for Predictive Preclinical Pharmaceutical Testing | 001 | 3 | NIH | 8/24/2018 | $812,637 |
| | 2018 | 2018 | AXOSIM, INC. | 1441 CANAL ST STE 206 | NEW ORLEANS | LA | 70112-2714 | ORLEANS | USA | R42TR001270 | Peripheral Nerve-on-a-chip for Predictive Preclinical Pharmaceutical Testing | 001 | 3 | NIH | 8/24/2018 | $27,223 |
| | 2018 | 2018 | AXOSIM, INC. | 1441 CANAL ST STE 206 | NEW ORLEANS | LA | 70112-2714 | ORLEANS | USA | R42TR001270 | Peripheral Nerve-on-a-chip for Predictive Preclinical Pharmaceutical Testing | 002 | 3 | NIH | 9/21/2018 | $240,000 |
| | 2018 | 2018 | AXOSIM, INC. | 1441 CANAL ST STE 206 | NEW ORLEANS | LA | 70112-2714 | ORLEANS | USA | R43ES029886 | Development of 3D Rat Nerve-on-a-Chip Model for Chemical Toxicity Screening | 000 | 1 | NIH | 9/21/2018 | $197,625 |
|
| Issue Date FY: 2017 ( Subtotal = $963,541 ) |
| | 2017 | 2017 | AXOSIM TECHNOLOGIES LLC | 1441 CANAL ST | NEW ORLEANS | LA | 70112-2714 | ORLEANS | USA | R42TR001270 | Peripheral Nerve-on-a-chip for Predictive Preclinical Pharmaceutical Testing | 000 | 2 | NIH | 7/13/2017 | $963,541 |
| | 2017 | 2016 | AXOSIM TECHNOLOGIES LLC | 1441 CANAL ST | NEW ORLEANS | LA | 70112-2714 | ORLEANS | USA | R41TR001270 | Peripheral Nerve-on-a-chip for Predictive Preclinical Pharmaceutical Testing | 000 | 1 | NIH | 5/12/2017 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $224,859 ) |
| | 2016 | 2016 | AXOSIM TECHNOLOGIES LLC | 130 S GENOIS ST | NEW ORLEANS | LA | 70119 | ORLEANS | USA | R41TR001270 | Peripheral Nerve-on-a-chip for Predictive Preclinical Pharmaceutical Testing | 000 | 1 | NIH | 1/19/2016 | $224,859 |
|
|
